Pancreatic cancer (PC) and associated pre-neoplastic lesions have been reported to be hypoxic, primarily due to hypovascular nature of PC. Though the presence of hypoxia under cancerous condition has been associated with the overexpression of oncogenic proteins (MUC1), multiple emerging reports have also indicated the growth inhibitory effects of hypoxia. In spite of being recognized as the top-most differentially expressed and established oncogenic protein in PC, MUC4 regulation in terms of micro-environmental stress has not been determined. Herein, for the first time, we are reporting that MUC4 protein stability is drastically affected in PC, under hypoxic condition in a hypoxia inducible factor 1α (HIF-1α)-independent manner. Mechanistically, we have demonstrated that hypoxia-mediated induction of reactive oxygen species (ROS) promotes autophagy by inhibiting pAkt/ mTORC1 pathway, one of the central regulators of autophagy. Immunohistofluorescence analyses revealed significant negative correlation (P-value = 0.017) between 8-hydroxy guanosine (8-OHG) and MUC4 in primary pancreatic tumors (n = 25). Moreover, we found pronounced colocalization between MUC4 and LAMP1/LC3 (microtubule-associated protein 1A/1B-light chain 3) in PC tissues and also observed their negative relationship in their expression pattern, suggesting that areas with high autophagy rate had less MUC4 expression. We also found that hypoxia and ROS have negative impact on overall cell growth and viability, which was partially, though significantly (Po0.05), rescued in the presence of MUC4. Altogether, hypoxia-mediated oxidative stress induces autophagy in PC, leading to the MUC4 degradation to enhance survival, possibly by offering required metabolites to stressed cells.
INTRODUCTION
Pancreatic cancer (PC) is the fourth leading cause of cancerrelated mortalities in United States with an overall survival rate of only 6%. 1 Currently, gemcitabine is used as a standard therapy for advanced PC; however, its clinical outcome is quite modest due to development of acquired and inherent chemo-resistance. One of the prominent features of PC that contributes to this chemoresistance and malignant progression is the presence of extreme hypoxia. Unlike other solid tumors, PC is hypovascular and characterized by enormous desmoplastic reaction. 2, 3 Tumor hypoxia is a condition when cancer cells are deprived of oxygen and is primarily found in regions that are distant from the tumor blood vessels, particularly, center of the tumor. Therefore, these microenvironments suffer from low nutrient availability and accumulation of waste products (acidosis). Ultimately, it results in the development of a stressful environment that adversely affects tumor cell proliferation and survival, and leads to the clonogenic selections of only those cells who can withstand this hostile environment. 4 To survive and remain viable, cancer cells induce both HIF-1α-dependent and -independent mechanisms.
PC is characterized by aberrant mucin expressions, such as MUC1, MUC4 and MUC5AC. [5] [6] [7] [8] Under normal condition, the expression of these mucins is low or undetectable, but under cancerous conditions, their expression increases. Studies have established that MUC1, a transmembrane protein, is positively regulated by hypoxia and has been linked with increased survival, angiogenesis and altered metabolomics in PC. [9] [10] [11] Similar to MUC1, MUC4 is also a transmembrane protein, but it does not express in normal pancreas. 12 MUC4 appears quite early in preneoplastic stage (pancreatic intraepithelial neoplasia-I), and its expression increases with the progression of the disease. 7 We have previously established that aberrant overexpression of MUC4 leads to increased tumor growth, survival, metastasis and therapy resistance in PC. [13] [14] [15] So far, various intrinsic and extrinsic factors have been associated with its aberrant expression during PC progression. 16 However, how environmental stimuli such as hypoxia can regulate MUC4 expression is still not clear.
Therefore, in the present study, we investigated the regulation of MUC4 expression by hypoxia, and examined the clinical significance of this association in PC. Our findings indicate that hypoxia negatively regulates MUC4 expression in PC, and also provided evidence for a novel regulatory mechanism, which leads to MUC4 degradation due to hypoxia-induced oxidative stress.
RESULTS

MUC4 expression is downregulated in PC cell lines in response to hypoxia
To understand the effect of hypoxia in MUC4 expression, we treated MUC4 expressing PC cell lines, CAPAN1, CD18/HPAF and T3M4, with 1% of hypoxia for 24 h. There was significant downregulation of MUC4 at the protein level in all three PC cell lines (Figure 1a) , with a concomitant increase in HIF-1α levels. Substantially, we observed a similar decrease in MUC4 levels in hypoxia-treated Colo357 cells (Supplementary Figure 1A) . Immunofluorescence analysis also validated reduction in MUC4 expression, whereas MUC1, an established HIF-1α target, was significantly increased in CD18/HPAF cells (Figure 1b) . To further substantiate our findings, we gave prolong (or chronic) hypoxia to CD18/HPAF cells for 72 and 96 h. Consistently, we observed significant downregulation of MUC4, whereas MUC1 expression remains persistently high (Figure 1c) . However, quantitative realtime PCR (qRT-PCR) analysis showed insignificant reduction in MUC4 expression at transcript levels in all tested PC cell lines (Figure 1d ), suggesting that hypoxia may affect the stability of MUC4 protein. Altogether, the results indicate that MUC4 expression reduces under hypoxic condition due to modulation in MUC4 protein stability.
Hypoxia decreases MUC4 expression independent of HIF-1α Previous studies have linked hypoxia-mediated alterations in mucins expression with induced HIF-1α expression, [9] [10] [11] 17, 18 which led us to ask whether hypoxia-mediated downregulation of MUC4 expression is HIF-1α dependent. To ascertain the role of HIF-1α transcription factor in MUC4 reduction, we silenced HIF-1α expression by utilizing shRNA approach and by pharmacological inhibitor, YC-1. Under both normoxic and hypoxia conditions, HIF-1α knocked down (kd) led to MUC4 downregulation in CAPAN1 cells, as compared to its respective control (Figure 2a) . Furthermore, treatment of both CD18/HPAF and CAPAN1 cells with YC-1 inhibited the expression of MUC4 in a dose-dependent manner (Figure 2b ), suggesting the role of HIF-1α in the upregulation of MUC4 expression. Additionally, inhibition of HIF-1α degradation upon MG132 (ubiquitin-proteasome inhibitor) treatment of CD18/HPAF cells did not rescue MUC4 degradation, in fact further decrease in MUC4 expression was observed (Figure 2c ), possibly due to MG132-mediated induction of autophagy. [19] [20] [21] These data further strengthened the fact that reduced MUC4 protein expression under hypoxia is HIF-1α independent, and it is the stability of MUC4 which is primarily affected under hypoxia. To further prove our conjecture, we treated CD18/HPAF cells with cycloheximide (CHX, protein translation inhibitor) for indicated time points and observed significant decrease in MUC4 expression under hypoxic condition as compared with normoxia (Figure 2d ), establishing that MUC4 protein stability is reduced under hypoxic conditions. Immunofluorescence analysis in PC tissues (n = 25) also revealed 56% (14/25) and 68% (17/25) expression of MUC4 and HIF-1α, respectively. MUC4 and HIF-1α were co-expressed in 44% (11/25) of patients, however, were simultaneously absent in 20% (5/25) of PC patients (Figure 2e, Supplementary Figure 1B) . Altogether, the results indicate that MUC4 expression is positively associated with HIF-1α; therefore, hypoxia-mediated downregulation of MUC4 is HIF-1α independent.
Decrease in MUC4 expression under hypoxia is reactive oxygen species dependent Because hypoxia-mediated reduction in MUC4 is HIF-1α independent, therefore, our next question was to explore the mechanism responsible for significant downregulation of MUC4 expression under hypoxia. It is already known that hypoxia has various HIF-1α-dependent and -independent mechanisms. 22 Recent studies have shown that mucins expression is regulated by reactive oxygen species (ROS), 23 and induction of ROS under hypoxia, is an established feature. It prompted us to ask whether hypoxiamediated ROS induction is responsible for MUC4 reduction. To address this question, we treated CD18/HPAF cells with 5 mM of ROS scavenger; N-acetyl cysteine (NAC), for 24 h in the presence and absence of hypoxia. Interestingly, we observed attenuation of MUC4 reduction under hypoxic condition in NAC-treated cells (Figure 3a) . Notably, NAC treatment alone was sufficient for MUC4 upregulation ( Supplementary Figure 2A) , by attenuating basal levels of ROS already present in PC cell lines (Figure 3b , Supplementary Figure 2B ). The measurement of DCFDA (2′,7′-dichlorofluorescin diacetate) fluorescence showed 41 and 63% reduction in ROS levels upon NAC treatment under both normoxic and hypoxic conditions, respectively, further strengthening that NAC-mediated neutralization of ROS is responsible for MUC4 upregulation (Figure 3b ). Treatment of both CD18/HPAF and CAPAN1 PC cells with another antioxidant, α-tocopherol succinate (α-TS), also showed a similar increase in MUC4 expression (Figure 3c ). Additionally, treatment of CAPAN1 with exogenous hydrogen peroxide (H 2 O 2 ), a form of non-ionic ROS, resulted in concomitant reduction in MUC4 expression in a dosedependent manner (Figure 3d ), which was further confirmed in CD18/HPAF cells (Figure 3e ). Immunofluorescence experiment also exhibited that the negative impact of hypoxia and ROS on MUC4 expression was abolished in the presence of NAC (Figure 3f ). Altogether, these data suggest that ROS is playing a key role in hypoxia-mediated negative regulation of MUC4 in PC.
Hypoxia-mediated autophagy induction leads to reduced MUC4 stability As demonstrated earlier, inhibition of ubiquitin-proteasome pathway failed to rescue MUC4 suppression under hypoxic condition (Figure 2c ). Multiple studies have established that autophagy and ubiquitin proteasome systems are functionally coupled, and Inhibition of ubiquitin-proteasome pathway, failed to rescue MUC4 degradation, whereas, HIF-1α protein which is known to be degraded solely by proteasome pathway was stabilized upon MG132 treatment under both normoxic and hypoxic conditions. (d) Similar to MG132, CD18/HPAF cells were pre-treated with CHX (50 μg/ml) for 30 min followed by 1% hypoxia treatment for 2, 4 and 6 h. 2% agarose gel electrophoresis was performed to see the effect of these inhibitor treatments on MUC4 expression in the presence or absence of hypoxia. We observed that CHX treatment significantly reduces the levels of MUC4 under hypoxic condition, compared to their respective controls, confirming the negative effect of hypoxia on MUC4 protein stability. (e) Representative images obtained from normal colon and PC tissues (from three different patients) showing MUC4 and HIF-1α co-expression (scale bar = 20 μM).
inhibition of ubiquitin proteasome system by MG132 induces autophagy. [19] [20] [21] Furthermore, the link between ROS and autophagy is also well established. 24, 25 Altogether, these studies incited us to propose that HIF-1α-independent hypoxia-mediated induction of oxidative stress promotes autophagy, which reduces the protein stability of MUC4. Therefore, we first evaluated the status of autophagy in PC cells, under hypoxic and oxidative stress conditions. Interestingly, the levels of microtubule-associated protein 1A/1B-light chain 3 (LC3)-I and II were significantly increased in hypoxia-treated CAPAN1 and CD18/HPAF cells compared with normoxic controls (Figure 4a ). Further, treatment of CAPAN1 cells with H 2 O 2 showed increased LC3-I and LC3-II expression levels in a dose-dependent manner (Figure 4b ). The results were verified in CD18/HPAF cells where an increase in LC3 was accompanied with the concomitant reduction in p62 expression (Figure 4c ), further emphasizing autophagy induction under oxidative stress conditions. Increased autophagosome formation in oxidative stress and hypoxic condition was also confirmed by monodansylcadaverine staining in CAPAN1 cells (Supplementary Figure 2C) . Further, treatment of CAPAN1 cells with increasing doses of rapamycin (RAP), an autophagy inducer by inhibiting mTORC1 complex, resulted in reduction in MUC4 expression in a dose-dependent manner, with concomitant increase in LC3-I and II levels ( Figure 4d ). These results were substantiated by treatment of CAPAN1 cells with autophagy inhibitor, vinblastine (VB) 26, 27 in the presence and absence of ROS. Consistent to our premise, the suppression of MUC4 expression by ROS was significantly abolished by VB treatment, as compared to Figure 2D ). To further substantiate our findings, we did immunofluorescence staining for MUC4 and LAMP1+ lysosomal vesicles in CAPAN1 and observed their colocalization (Figure 4g ). Moreover, a significant increase in MUC4 expression upon ATG7 kd in CD18/HPAF cell line establishes the involvement of autophagy in MUC4 degradation (Figure 4h) . Altogether, we have demonstrated that hypoxiamediated ROS stimulation causes induction of autophagy process, which leads to MUC4 degradation and reduced stability.
Hypoxia inhibits Akt/mTORC1 pathway to induce autophagy Recent report by Wang et al. 28 has demonstrated the involvement of Akt activation in mTORC1 regulated autophagy process. Additionally, chronic hypoxia has also shown to suppress Akt activation in hypoxia-treated PC cells. 29 Similarly, we also observed that levels of phosphorylated Akt and mTORC1 effector, pS6 kinase, were consistently reduced in hypoxia-treated PC cells, whereas expression of EGFR, pEGFR, Akt and S6 kinase remained unchanged ( Figure 5a ). We observed significant reduction in p53 expression in hypoxia-treated cells lines, suggesting the possible accumulation of genomic and cellular defects in stressed PC cells.
We also observed an increase in p21 expression in hypoxia-treated T3M4 and CD18/HPAF cells, suggestive of growth arrest of PC cells (Supplementary Figure 3A) , which was corroborated by our growth kinetics analysis in hypoxia-treated and untreated CD18/HPAF cells ( Figure 5b ) and by a recent study where hypoxia has shown to cause growth inhibition in PC cell lines. 30 To assess the role of ROS on pAkt reduction, we analyzed its expression in the presence and absence of NAC. Interestingly, hypoxia-mediated downregulation of pAkt in CD18/HPAF cells was abolished upon NAC administration, further emphasizing that the reduction in pAkt levels under hypoxia is ROS dependent (Figure 5c ). From these data, we were also able to reasoned that p53 downregulation under hypoxia is occurring due to induced expression of MDM2 (ubiquitin ligase), though we did not see any change in their levels after NAC treatment, implying the involvement of ROSindependent mechanisms in these alterations. Further, treatment with NAC attenuates the growth inhibitory effects of hypoxia ( Figure 5d ) and H 2 O 2 (ROS stress) on PC cells (Supplementary Figure 3B) . These results were further supported by performed MTT (3-[4,5-dimethylthiozol-2-yl]-2,5diphenyltetrazoliumbromide) assay as significant loss in cell viability (P o 0.05) was noticed in H 2 O 2 -treated PC cells (Supplementary Figure 3C) . To know the effect of hypoxia on cell viability and death, MTT assay was performed. CD18/HPAF cells exhibited significant loss of viability under hypoxia, which was partially rescued in the presence of ROS scavenger (NAC) and further augmented upon autophagy inhibitor chloroquinone (CQ) treatment (Figure 5e ). Similar to growth kinetics (Figure 5d ), under normoxia, NAC did not demonstrate any change in cell viability, whereas CQ significantly reduces the cell viability. Interestingly, PC cell lines demonstrate high autophagy rate even at basal levels (Supplementary Figure 4A) , affirming protumorigenic role of autophagy in PC, 25 which is further corroborated by our MTT experiment, where significant (P o 0.05) reduction in cell viability was observed in a dose-dependent manner in VB-treated PC cells (Supplementary Figure 4B ). Consistent to cell viability results, we observed increased cellular apoptosis and necrosis upon hypoxia treatment (P o 0.05), which was significantly (P o 0.05) suppressed by NAC and augmented by CQ treatment (Figure 5f ), suggesting that reduction in PC cell viability and death under hypoxic condition is oxidative stress dependent, and induction of autophagy is a survival mechanism.
To determine the role of MUC4 in the survival of PC cells under hypoxia and oxidative stress, we gave 1% hypoxia treatment to MUC4 kd and scrambled (Scr) CAPAN1 cells (Figure 5g ). Noticeably, under hypoxia, MUC4 scr CAPAN1 cells exhibited 6, 21 and 53% reduction in cell viability on days 1, 3 and 5, respectively, compared with normoxic cells. On the other hand, MUC4 kd cells exhibited 10, 27 and 64% loss in cell viability on days 1, 3 and 5, respectively, compared with normoxic kd cells, suggesting the role of MUC4 in maintaining the viability of PC cells under stressed condition (Figure 5h ). Similar results were obtained when MiniMUC4 overexpressing MIA PaCa-2 cell model was used. 31 In this model, MUC4 non-expressing MIA PaCa-2 cell line ectopically express MiniMUC4, which consists only 10% of the total variable number of tandem repeats (VNTR) of wild-type MUC4 (Supplementary Figure 3D) . Growth kinetics was performed in these cells for 24 Figure 3E) . At 48 h, we observed 71 and 55% reduction in cell numbers in H 2 O 2 -treated vector and MiniMUC4 expressing MIA PaCa-2 cells, respectively. Administration of NAC was able to rescue H 2 O 2 -mediated decrease in cells numbers in vector and MiniMUC4 expressing MIA PaCa-2 (Supplementary Figure 3E) . These results indicate that the presence of MUC4 alone cannot completely abolish oxidative stress-facilitated PC death. However, the presence of MUC4 does offer better survival and viability advantage to PC cells under hypoxic and oxidative stress conditions than MUC4 kd or null cells.
Clinical validation of MUC4 association with oxidative stress and degradation via lysosomal pathway To validate the link between MUC4 and hypoxia-induced autophagy, we performed immunofluorescence analysis for MUC4 and LAMP1 in PC tissues, and observed significant colocalization between them (Figure 6a) . One of the consistent and intriguing finding was the inverse relationship between LAMP1 and MUC4 expression. Ducts having high MUC4 expression exhibited low expression of LAMP1 and vice versa, as demonstrated in the intensity plot diagram (Supplementary Figure 5A) . Owing to the established association of increased expression of LAMPs with increased lysosomal function and autophagy involvement, 32 their inverse expression pattern may indicate that MUC4 does enter to the lysosomes, and may undergo degradation. Additionally, the presence of MUC4 in LC3-positive vesicles in PC tissues confirmed the association between MUC4 with autophagy (Supplementary Figure 5B) .
To know the clinical association between MUC4 and oxidative stress, we performed immunofluorescence analysis by staining PC tissues for MUC4 and 8-hydroxy guanosine (8-OHG, commonly used marker for oxidative stress). 33, 34 We observed 8-OHG and MUC4 expression in 64 and 56% of PC patients, respectively. Validating our in vitro data, MUC4 and 8-OHG expression exhibited significantly inverse relationship under in vivo condition, as shown in representative images ( Figure 6b ) and their respective intensity plots (Supplementary Figure 5C) . It was further established by quantifying the mean fluorescence intensities (MFIs) of 8-OHG in MUC4 low (MUC4 L ) and MUC4 high (MUC4 H ) regions, and the difference was found to be statistically significant (P = 0.017) (Figure 6b) . In our analysis, we also observed that oxidative stress does not always correlate with increased HIF-1α expression (Figure 6c Figure 6d ). Altogether, we can conclude that MUC4 expression is differentially regulated by HIF-1α and oxidative stress, which is possible in complex and varied PC microenvironment.
DISCUSSION
By far, PC has one of the most complicated microenvironment among other solid cancers due to its myriad of unique properties. 3 Unlike most of the solid tumors, PC is characterized by hypovascularization due to the deposition of extracellular matrix, which causes extreme hypoxia and oxidative stress. 3 Chronic and severe hypoxia has been shown to inhibit tumor cell proliferation, which ultimately led to cell death. 35 Nevertheless, tumor hypoxia is also the predict marker for the worse clinical outcome. To resolve these two opposite observations, hypoxia has been projected to create a selection pressure, which causes the survival of only those clones that are highly aggressive and resistant toward fluctuating microenvironmental stress. 36 Alike, aberrant overexpression of mucins has been implicated in PC survival, aggressiveness, drug resistance and maintenance of stem cell phenotype. 3, [13] [14] [15] Most of these attributes are frequently assign to their interaction with receptor tyrosine kinases, cell surface proteins and components of extracellular matrix. 37, 38 Present study provides an additional oncogenic mechanism, by which MUC4 contributes to the survival of PC cells under hypoxic conditions through its degradation via autophagy. Among various cancers, such as renal cancer and PC, the hypoxia-mediated induction of MUC1 has been associated with HIF-1α.
9-11 Nevertheless, we observed a significant reduction in MUC4 expression under hypoxia in multiple PC cell lines. Intriguingly, we observed that similar to MUC1, MUC4 is also positively regulated by HIF-1α, however, in spite of increased HIF-1α stability (by inhibiting its proteosomal degradation); MUC4 was degraded persistently under hypoxic condition. Therefore, downregulation of MUC4 expression under hypoxia, even in the presence of induced HIF-1α expression, signifies the presence of other predominant pathways independent of HIF-1α.
Hypoxia-mediated negative regulation of MUC4 S Joshi et al
Studies have demonstrated that ROS induction is one of the most common HIF-1α-independent mechanism activated under hypoxic conditions. 39 Moreover, the established role of ROS in autophagy induction 40 and emerging data linking mucins regulation by ROS 23 prompted us to postulate that ROS-induced autophagy has crucial role in MUC4 downregulation. Consistent to our proposition, we did observe MUC4 downregulation under hypoxic or chemically-induced (RAP) autophagy, which was attenuated upon inhibition of ROS and autophagy. So far, studies have not demonstrated the involvement of autophagy in mucins The graphical representation to demonstrate the effect of hypoxia and neutralization of consequently produced ROS (by concomitant treatment with 2.5 mM of NAC) on the proliferation of CD18/HPAF and CAPAN1 cell lines. (e) To explore the role of hypoxia-induced oxidative stress and autophagy on cell death and viability, MTT assay was performed. CD18/HPAF cells were exposed to 1% hypoxia in the presence and absence of NAC (2.5 mM) and CQ (50 μM) for 24 h. Post-treatment, MTT assay was performed and optical density was measured at 570 nm. (f) The graphical representation of Annexin (indicator of early apoptosis) and propidium iodide (PI, indicator of late apoptosis and necrotic cells) staining performed on CD18/HPAF cells treated for 24 h with hypoxia alone, hypoxia followed by NAC (2.5 mM) or CQ (50 μM) treatment for further 12 h. (g) Immunoblot confirming MUC4 knocked down in CAPAN1 cells. (h) The graphical representation to demonstrate the effect of 1, 3 and 5 days of hypoxia treatment on the proliferation of MUC4 kd and scr CAPAN1 cells (LE, low exposure; P o0.05: statistically significant; **Po 0.01: statistically significant; ns, no significant difference).
degradation. The apparent presence of MUC4 in LAMP1-and LC3-positive vesicles in PC tissue implies that MUC4 does enter to autophagy/lysosomal pathway under in vivo, and provided the first evidence of mucin degradation by autophagy pathway. Despite both cancer promoting and suppressing role of autophagy, majority of the available data hints toward its role in promoting survival and proliferation of PC cells. 25, 41 Our study also suggests that MUC4 degradation via ROS-mediated autophagy might be a survival mechanism in PC, as MUC4 kd CAPAN1 and MUC4-null MIA PaCa-2 cell lines were less viable under microenvironmental stress conditions compared with CAPAN1/ Scr and MiniMUC4 expressing MIA PaCa-2 cells, respectively. Recent studies have clearly established that pancreatic tumors are nutrient deprived and heavily dependent on macropinocytosis, leading to uptake of small extracellular proteins by cancer cells. 42, 43 These internalized proteins then undergo autophagy process and provide necessary metabolites to ensure the survival of highly stressed PC cells. Because of reportedly reduced levels of extracellular proteins concentration under clinical settings, 44, 45 we anticipate that requirement or dependency to internalize and degrade overexpressed membrane proteins (such as MUC4) by hypoxic/oxidatively stressed/nutrient deprived PC cells is conceivably more than extracellular proteins and needs further investigations.
Mechanistically, we observed significant downregulation of phospho-Akt in hypoxia-treated PC cells. Attenuation of ROS level by NAC treatment suppresses the hypoxia facilitated Akt activation, which was further related with the resumption of cell proliferation. These data were further supported by a recent report by Sayin et al. 46 where in vivo administration of NAC and vitamin E have demonstrated to increase the tumorigenicity of lung cancer by downregulating the levels of ROS, DNA damage and p53. 46 We also observed downregulation of p53 under hypoxia, which further reduces upon ROS attenuation, and therefore, questioned the utility of antioxidant-based therapies in PC. Looking into earlier clinical trials on dietary antioxidants in cancer condition, we have not received encouraging results. 47, 48 Moreover, NAC treatment leads to the attenuation of apoptotic functions of ROS inducers, further emphasizing toward the optimization of antioxidant therapies against PC. 49 However, due to observed overexpression of HIF-1α even under normoxic condition, current study encourages HIF-1α targeting, which will led to the downregulation of multiple oncogenic proteins, including mucins. It will definitely be our future interest to observe how HIF-1α inhibition leads to MUC4 downregulation. Our in silico analysis has shown that MUC4 promoter does not contain HIF-1α bindings sites, indicating the involvement of other protein mediators in HIF-1α facilitated MUC4 regulation. One of the possible mechanisms could be EGFR downregulation upon HIF-1α inhibition, as recent study from our laboratory has shown that inhibition of EGFR leads to MUC4 downregulation in PC cells, and needs to be investigated. 50 In conclusion, the present study provides evidence that hypoxia negatively regulates MUC4 expression in PC by affecting its stability. Moreover, we found that hypoxia-mediated reduction of MUC4 is HIF-1α independent, and involves ROS-induced autophagy in MUC4 degradation ( Figure 7 ). Similar to cytokines, we observe functional redundancy in mucins, implying that induction in MUC1 expression under hypoxia may be sufficient to compensate for MUC4 downregulation that needs to be addressed. Finally, due to the diverse effect of hypoxia and highly complicated PC microenvironment, we can speculate that MUC4 expression could be differentially regulated by HIF-1α and oxidative stress, which leads to differential expression and Figure 7 . Schematic presentation of the summary of the paper. Hypoxia is induced collaboratively by hypovascularization, desmoplastic reactions and continuous proliferation of tumor cells, which further leads to increased ROS production and generate oxidative stress condition. Produced ROS inhibits the activation of Akt, which further leads to mTORC1 inhibition and induction of autophagy. Induce autophagy facilitates MUC4 degradation. The inhibitors used in this study suppress the activity of different proteins. For example, NAC and α-TOS act as ROS scavenger, RAP inhibits mTORC1 and VB inhibits the fusion of autophagosomes (AP) with lysosomes (L) and thus, prevent the formation of autophagolysosomes that causes MUC4 accumulation.
regulation of MUC4 within the same tumor due to the different local microenvironment. Table S1 ). Following primary antibody incubation, cells were washed and incubated with FITC and Texas red-conjugated secondary antibodies.
MATERIALS AND METHODS
To label autophagic vacuoles, hypoxia and H 2 O 2 -treated PC cells were incubated with 50 μM of monodansylcadaverine (Sigma-Aldrich) at 37°C for 10 min. 52 After incubation, cells are washed four times with PBS; coverslips were mounted and immediately analyzed. All the images were taken by using LSM 510 microscope, a laser scanning confocal microscope (Carl Zeiss GmbH, Thornwood, NY, USA) in the respective channels. The intensity colocalization plot was made by using the Zen lite 2012 software (Zeiss Microscopy, Oberkochen, Germany). Image J software was used to determine the Pearson correlation coefficient and MFI values for both 8-OHG and MUC4. For box plot (Figure 6b Growth inhibition and growth kinetics assay For the growth inhibition assay, 5 × 10 3 PC cells were plated onto flatbottomed 96-well plates (Costar, Corning, NY, USA). After 24 h, cells were treated with 1% hypoxia and indicated concentrations of H 2 O 2 , NAC and VB for an additional 24 h. Subsequently, MTT assay was performed as per the standard procedure.
For growth kinetics assay, 50 × 10 3 PC cells were plated in triplicates into six-well plates in triplicates and cultured in serum-free DMEM for 12 h. Following, cells were first pre-treated with NAC (2.5 mM) for 30 min and then incubated with 1% hypoxia or oxidative stress condition (H 2 O 2 ). Cells were counted at indicated time points by using automated cell counter (Countess, Invitrogen).
Statistical analysis
All results are representative of at least three independent experiments. The data are expressed as the mean ± s.d. Statistical comparisons of two groups were made using a two-tailed t-test in all the performed experiments, where P-value less than 0.05 was considered as statistically significant. For correlation analysis, Pearson and regression coefficients were determined between two groups. 
